Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Biotech 2011 Company Profile

01:46 EDT 20th April 2014 | BioPortfolio

Designed to advance the bioiscience industries in the mid-Atlantic region, the Biotech symposium each year attracts top executives from the region's global pharmaceutical, biotechnology, medical device, and diagnostic companies; venture capitalists and other investors; university researchers; university-industry liaison officers; government officials; and support organizations. This must-attend event will feature thought-provoking panel discussions, dynamic plenary sessions, renowned keynote speakers, an Innovation Forum, an Exhibit Hall, and much more.


News Articles [818 Associated News Articles listed on BioPortfolio]

2013′s Untold Biotech Story: Success Of The 2011-12 IPO Class

The past year has certainly been the most exciting one for Biotech IPOs since 2000, with dozens of new offerings and compelling therapeutic narratives.  But focusing on these new IPOs misses an equal...

France 2nd in the world?

France Biotech has presented its 2011 biotech survey together with France Biotech. The results are very favorable for the country.

Stocks drop; Biotech takes another plunge

The Nasdaq had its worst day since 2011 as investors dumped biotechnology shares and other industries that have soared over the past year. Biogen Idec, Gilead Sciences and other biotech companies plun...

BB Biotech: Biotech-Sektor weiterhin positiv - Aktiennews

Schaffhausen - Der Nasdaq Biotech Index legte im 4. Quartal nochmals um 8.3% (in USD) zu, sodass 2013 zu einem der besten Biotech-Jahre avancierte, so die BB Biotech AG (ISIN: CH0038389992, WKN: A0...

Tech and Biotech Stocks Slump

Biotech and tech stocks have been in a slump for the past three weeks, evidenced in part by the 3.1 percent drop in the Nasdaq Composite — the worst one day percentage decline, according to MarketWa...

2013’s Untold Biotech Story: Success Of The 2011-12 IPO Class

The past year has certainly been the most exciting one for Biotech IPOs since 2000, with dozens of new offerings and compelling therapeutic narratives.  But focusing on these new IPOs misses an equal...

Research Reports on Adoption of Commercialized GM/Biotech Crops by Small-scale Farmers in China, India, and the Philippines

In 2012, a record 17.3 million farmers, up 0.6 million from 2011, grew biotech crops. Of these small-scale farmers adopting biotech crops, 85% come from China, India, and the Philippines combined. The...

No CHMP recommendation yet on Teva's laquinimod

Active Biotech AB (SSE:ACTI) said partner Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) was notified by EMA's CHMP that the committee has not reached a decision on an MAA for laquinimod to treat rel...

Drugs and Medications [151 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [377 Associated PubMed Articles listed on BioPortfolio]

Biotech methods and advances.

Cover illustration: Our latest Biotech Methods & Advances special issue is edited by our Editors-in-Chief Prof. Alois Jungbauer and Prof. Sang Yup Lee. As always, the special issue is a collection of...

Editorial: Latest methods and advances in biotechnology.

The latest "Biotech Methods and Advances" special issue of Biotechnology Journal continues the BTJ tradition of featuring the latest breakthroughs in biotechnology. The special issue is edited by our...

What's fueling the biotech engine-2012 to 2013.

Biotech patents and science policy: the Spanish experience.

Decreasing cardiovascular risk in HIV infection between 2005 and 2011.

Cardiovascular risk profile was compared in 765 Italian HIV-infected outpatients enrolled in 2005 and in 765 individually age-matched and sex-matched patients enrolled in 2011. Median Framingham risk...

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will b...

Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement

This is a single-center, open-label, randomized, active-controlled study to compare DR-2011 to progesterone vaginal gel for luteal phase replacement.

Flu Vaccine Study in Neuromuscular Patients 2011

The purpose of the study is to compare the immune response of two different injection methods (Intramuscular V.S. Subcutaneous) of the 2011-2012 seasonal Influenza (Flu) vaccine among pati...

Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM

The aim of this study is to evaluate the immune response and the safety of one injection of FluarixTM/ Influsplit SSW® 2010/2011 or Pandemrix TM in subjects who had received a single Pand...

Yearly Strain Variation Study, 2010/2011

The purpose of the study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/201...

Companies [1086 Associated Companies listed on BioPortfolio]

PBS Biotech Inc.

PBS Biotech, based in Camarillo, California, has developed the new generation PBS Single Use Bioreactors with patented unique Air-wheel™ mixing technology. PBS Biotech is one...

Hookipa Biotech AG

Hookipa Biotech, founded in Vienna, Austria in summer 2011, develops a new class of innovative prophylactic and therapeutic vaccines based on its proprietary Vaxwave® technology. The Vaxwave&r...

Biotech 2011

Designed to advance the bioiscience industries in the mid-Atlantic region, the Biotech symposium each year attracts top executives from the region's global pharmaceutical, biotech...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

More Information about "Biotech 2011" on BioPortfolio

We have published hundreds of Biotech 2011 news stories on BioPortfolio along with dozens of Biotech 2011 Clinical Trials and PubMed Articles about Biotech 2011 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotech 2011 Companies in our database. You can also find out about relevant Biotech 2011 Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement